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Most Rare Missense Alleles Are Deleterious in Humans:
Implications for Complex Disease and Association Studies
Gregory V. Kryukov, Len A. Pennacchio, and Shamil R. Sunyaev
The accumulation of mildly deleterious missense mutations in individual human genomes has been proposed to be a
genetic basis for complex diseases. The plausibility of this hypothesis depends on quantitative estimates of the prevalence
of mildly deleterious de novo mutations and polymorphic variants in humans and on the intensity of selective pressure
against them. We combined analysis of mutations causing human Mendelian diseases, of human-chimpanzee divergence,
and of systematic data on human genetic variation and found that ∼20% of new missense mutations in humans result
in a loss of function, whereas ∼27% are effectively neutral. Thus, the remaining 53% of new missense mutations have
mildly deleterious effects. These mutations give rise to many low-frequency deleterious allelic variants in the human
population, as is evident from a new data set of 37 genes sequenced in 11,500 individual human chromosomes. Sur-
prisingly, up to 70% of low-frequency missense alleles are mildly deleterious and are associated with a heterozygous
fitness loss in the range 0.001–0.003. Thus, the low allele frequency of an amino acid variant can, by itself, serve as a
predictor of its functional significance. Several recent studies have reported a significant excess of rare missense variants
in candidate genes or pathways in individuals with extreme values of quantitative phenotypes. These studies would be
unlikely to yield results if most rare variants were neutral or if rare variants were not a significant contributor to the
genetic component of phenotypic inheritance. Our results provide a justification for these types of candidate-gene
(pathway) association studies and imply that mutation-selection balance may be a feasible evolutionary mechanism
underlying some common diseases.
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Many common human diseases have a strong heritable
component. Although the field of modern human genet-
ics has been incredibly successful in determining the ge-
netic causes of rare Mendelian diseases, complex diseases
have proven to be a more challenging problem.1,2 Genetic
variation that influences an individual’s susceptibility to
most such diseases is still largely unidentified. Of special
interest are missense mutations, since many of them are
believed to have nonmarginal functional effects.1 The ef-
fects of a missense mutation on molecular function, phe-
notype, and organism fitness can be extremely diverse. A
missense mutation can be lethal or can cause severe Men-
delian disease; alternatively, it can be mildly deleterious,
effectively neutral, or beneficial. Knowledge of relative fre-
quencies of these types of mutations and their contribu-
tions to population genetic variation is important for un-
derstanding the evolutionary background of common
disease and can inform design of human genetic studies.
The effect of a missense mutation on an organism is
always multifaceted and can be considered from multiple
perspectives—biochemical, medical, and evolutionary.
The relationship between the effects of amino acid sub-
stitution on protein activity, human health, and an in-
dividual’s evolutionary fitness is not trivial. A mutation
that damages protein structure does not necessarily lead
to a detectable human-disease phenotype, and a mutation
that predisposes an individual toward a disease is not nec-
essarily evolutionarily deleterious. Fixation of completely
deactivating mutations (pseudogenezation) was appar-
ently a common event during recent human evolution,3
indicating that a mutation that abolishes protein activity
is not necessarily subject to purifying selection. Substi-
tutions leading to abnormal hemoglobin function that
cause sickle-cell anemia are apparently negative from both
biochemical and medical points of view. Nevertheless,
they cannot be considered negative from an evolutionary
point of view, because balancing selection has brought
them to high frequency in many parts of the world as a
result of malaria resistance in heterozygotes. To clearly
distinguish different aspects of negative mutations, we use
the term “damaging” to refer to a mutation that decreases
protein activity, the term “detrimental” to refer to a mu-
tation that predisposes an individual toward a disease, and
the term “deleterious” to refer to a mutation that has been
subject to purifying selection.
A high incidence rate for many complex diseases sug-
gests that a surprisingly high cumulative frequency of
medically detrimental variants should be present in the
human population. It remains uncertain why such poly-
morphisms can persist without being eliminated by pu-
rifying selection. Currently, two major lines of reasoning
exist that explain this apparent paradox. The first consid-
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ers various complex evolutionary scenarios and treats pos-
itive or balancing selection as a major force that can drive
medically detrimental mutations to high frequencies. The
second line of reasoning postulates a high mutation rate
as a major factor that determines the cumulative fre-
quency of detrimental polymorphisms in the population.
The first hypothesis states that the majority of poly-
morphisms predisposing an individual to a complex dis-
ease, although medically detrimental at the present time,
were not evolutionarily deleterious. There are several pos-
sible phenomena that might help a polymorphic variant
that confers susceptibility to a disease phenotype escape
purifying selection. One of them is a late disease onset,
when detrimental phenotypic consequences of a muta-
tion strike after reproductive age, and, thus, do not affect
the individual’s number of offspring. Several earlier stud-
ies, however, showed that this phenomenon is unlikely
to be common. These studies suggest that most of the
mutations that affect phenotypes at an old age also have
a small pleiotropic effect earlier in life.4,5 Changing direc-
tion of selection is another mechanism that can explain
how presently detrimental mutations could have escaped
purifying selection.6 Human lifestyle, environment, and
nutrition have changed dramatically, and some mutations
that were neutral or even beneficial in hunter-gatherer
societies tens of thousands of years ago might have be-
come medically detrimental in modern human society.
The best-known example of this type of reasoning is the
“thrifty genes” hypothesis,7 which postulates that poly-
morphisms that predispose modern humans to obesity
and are presently medically detrimental were able to rise
to high frequency in the population because of associated
selective advantages at the times of scarce food sources.
Yet another mechanism, balancing selection, can also
maintain deleterious mutations in a population if hetero-
zygous individuals have a strong evolutionary advantage.8
A classic example of this mechanism is the hemoglobin
mutation that is protective against malaria in a hetero-
zygote state and simultaneously leads to sickle-cell anemia
in a homozygous state.9 The fourth phenomenon that can
lead to a high frequency of medically detrimental muta-
tion is antagonistic pleiotropy, in which the negative ef-
fect of mutation on one trait is compensated by its positive
effect on another.10 None of these evolutionary scenarios,
however, have been shown to be frequent enough to ac-
count for a large number of human common complex
diseases.
The second theory postulates that the majority of med-
ically detrimental polymorphisms are also mildly evolu-
tionarily deleterious, and the observed frequency of dis-
ease-predisposing genetic variation is the result of
mutation-selection balance. The key assumption here is
that the majority of disease-causing mutations are both
medically detrimental and evolutionarily deleterious, but
the pressure of purifying selection acting on them is rea-
sonably weak. A high rate of mildly deleterious mutations
associated with disease risk counterbalances the action of
purifying selection.
Mutation-selection balance was, initially, treated theo-
retically by Kimura.11 Then, it was both advocated12 and
argued against13 as a mechanism capable of maintaining
a high level of genetic variance in natural populations. In
the last decade, partially because of the popularity of the
common disease–common variant hypothesis, mutation-
selection balance was frequently overlooked as a mecha-
nism that can explain the existence of many common,
harmful, heritable disorders. Recently, however, mutation-
selection balance has been put forward again as a plausible
mechanism for the maintenance of deleterious genetic
variation.14–16
Obviously, mutation-selection balance can become a
feasible evolutionary explanation for common disease
only if a sufficient fraction of de novo mutations in hu-
mans are mildly deleterious. The estimation of the fraction
of mildly deleterious missense mutations and the corre-
sponding fraction among low-frequency human poly-
morphisms is the subject of this work.
The evolutionary origin of present-day detrimental
polymorphism has an important implication for the spec-
trum of disease-predisposing alleles. If the majority of
medically detrimental mutations were not evolutionarily
deleterious, they might have risen to a high frequency in
the population, and thus the common disease–common
variant hypothesis is viable. On the contrary, if the ma-
jority of medically detrimental polymorphisms are mildly
deleterious and their cumulative high frequency in the
population is being maintained by mutation-selectionbal-
ance, then the common disease–rare variant alternative
hypothesis is likely to hold true. Given the high incidence
rate of many complex diseases, the mutation-selectionbal-
ance hypothesis can be feasible only if a large fraction
of de novo mutations is associated with moderate se-
lection coefficients, so that, despite being deleterious, they
can still achieve detectable frequencies in the human
population.
Earlier theoretical studies in the framework of a muta-
tion-selection model of common disease focused on the
frequency spectrum of susceptibility alleles. Pritchard17
and Pritchard and Cox18 argued that low-frequency alleles
are major contributors to common disease, whereas Reich
and Lander19 advocated the common disease–common
variant hypothesis. Pritchard17 suggested that the rate of
susceptibility mutations is high and that they are under
pressure of weak purifying selection, leading to an abun-
dance of rare variants. Reich and Lander19 did not focus
on the question of how an individual deleterious variant
could reach high population frequency. Given the high
frequency of the phenotype, they considered allelic iden-
tity in the disease class, which depended on the rate of
mutations conferring disease susceptibility. Thus, both
models depend on the rate of deleterious mutations in-
volved in disease and on the strength of selection against
new mutations. Both studies used estimates of mutation
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rate based on examples from a few loci and mutations
that cause fully penetrant Mendelian phenotypes; muta-
tions involved in complex disease, on the other hand, may
have smaller effects. The difference in conclusions is
mostly explained by the difference in numerical values of
the rate of deleterious mutations and the strength of se-
lection acting on them. It should be stressed that the del-
eterious mutation rate depends not only on the raw per-
nucleotide substitution rate but also on the fraction of de
novo mutations that are deleterious. Reliable estimation
of these parameters requires integration of several types
of data.
We combined, in our analysis, data on human Men-
delian disease–causing mutations, human-chimpanzee
divergence, and genetic variation in the modern human
population. The availability of new data on human poly-
morphism detected in 37 obesity-related genes sequenced
in 756 individuals allowed us to investigate the important
class of mildly deleterious mutations. Purifying selection
acting on this type of mutation is strong enough to ef-
fectively prohibit their fixation, but they are present in
the population at low frequencies and can be detected if
a large number of individuals is sequenced.
We estimated that 150% of de novo missense mutations
in an average human gene and 70% of missense SNPs
detected only once among 1,500 chromosomes are mildly
deleterious. Such mildly deleterious mutations are asso-
ciated with selection coefficients within a surprisingly nar-
row range of 0.001–0.003.
A high fraction of mildly deleterious mutations among
missense mutations suggests that mutation-selection bal-
ance can be a possible explanation for the existence of
common disease with complex inheritance. The obser-
vation that the majority of human rare nonsynonymous
variants are deleterious and thus, of significance for func-
tion and phenotype, strongly supports a resequencing
strategy for candidate-gene association studies; a disease
population is expected to have a higher rate of rare amino
acid variants in genes involved in disease than that of
healthy controls.
Data and Methods
Mutations Associated with Mendelian Diseases
For information on strongly detrimental mutations, we used the
Human Gene Mutation Database (HGMD),20 which contains
150,000 disease-causing mutations of various types, including
missense, nonsense, and splice-sites mutations. Disease-associ-
ated polymorphisms make up only a very small fraction of
HGMD, and the majority of mutations included in the database
are fully penetrant and cause simple Mendelian diseases.20 HGMD
lacks information on how many times each individual mutation
has been identified. However, with the assumption that muta-
tions follow the Poisson statistics, the presence of mutations de-
tected multiple times would not significantly affect our estimates
unless the majority of all possible nonsense mutations were de-
tected, which is highly unlikely for most genes.
HGMD may include genes with complete loss-of-function mu-
tations that are embryonically lethal. It contains some gain-of-
function mutations and mutations with incomplete penetrance.
Although the fraction of these mutations in HGMD is probably
small, their presence can cause bias of our estimates. Thus, we
repeated our analysis on a smaller but well-characterized set of
autosomal dominant or X-linked disease genes originally col-
lected by Kondrashov21 from locus-specific databases for esti-
mating the mutation rate in humans. We extracted information
on missense and nonsense mutations in these genes from indi-
vidual HGMD entries. To ensure that complete loss of function
is not lethal, we restricted our analysis to 26 genes that had at
least five reported nonsense mutations. All missense mutations
in these genes are believed to be loss-of-function mutations.
Human Polymorphism Data: New Large Resequencing
Data Set
For our analysis of very-low-frequency nonsynonymous SNPs, we
used a new large resequencing data set described by Ahituv et al.
(in this issue).22 Complete exonic sequences and their splice sites
were sequenced in 58 genes with potential involvement in obesity
in 379 obese and 378 lean individuals. Complete sequencing of
11,500 chromosomes provided us with an opportunity to study
nonsynonymous SNPs at very low frequencies. All individuals
included in the study are of white ancestry.
Since this data set is not based on a random population sample
and is phenotypically biased, we limited our analysis to 37 au-
tosomal genes for which no evidence of an effect on obesity was
detected. In these genes, there was no statistically significant ex-
cess of variation in either the obese or the lean group; 71 and 79
missense variants were found in lean and obese cohorts, respec-
tively. Random resampling of subsets matching the SeattleSNP
data set in size produced estimates highly similar to those ob-
tained from smaller systematic data sets, which further supported
the absence of bias in the chosen subset of 37 genes.
Human Polymorphism Data: Publicly Available Data
In addition to our new resequencing data set, we used three pub-
licly available data sets that contain sufficient information on
rare nonsynonymous alleles: (1) a data set generated by the Na-
tional Institute of Environmental Health Sciences Environmental
Genome Project (NIEHS-EGP) (NIEHS SNPs Program Web site),23
in which 1500 genes involved in DNA repair and cell-cycle path-
ways were sequenced in at least 90 unrelated individuals; (2) a
data set generated by the SeattleSNPs project (SeattleSNPs), in
which 1200 genes involved in the inflammatory responses were
sequenced in at least 46 individuals; and (3) a data set generated
by the database of Japanese Single Nucleotide Polymorphisms
(JSNP),24 in which polymorphic sites in 18,000 genes were dis-
covered using a panel of 12 individuals and were later genotyped
in 750 individuals.
Mutations Fixed in the Human Lineage after Divergence
from Chimpanzee
To obtain information on mutations fixed in the human lineage
after divergence from chimpanzee, we used human-chimpanzee
and human-macaque whole-genome pairwise alignments con-
structed with BLASTZ program. These alignments were obtained
from the University of California–Santa Cruz (UCSC) site (UCSC
Genome Bioinformatics: Sequence and Annotation Downloads).
We compared all nucleotide substitutions detected between hu-
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man and chimpanzee whole-genome assemblies with the dbSNP
database,25 which contains information on most of the known
human genetic variation. Substitutions that were detected as pre-
sent-day polymorphisms were excluded from our analysis of hu-
man-chimpanzee divergence. Macaque sequence was used as an
outgroup to distinguish mutations fixed in the human lineage
from mutations fixed in the chimpanzee lineage. Accordingly, we
ignored sites at which the macaque nucleotide was different from
both human and chimpanzee nucleotides. Because of this pro-
cedure, we potentially excluded a small fraction of very rapidly
evolving sites, thus slightly underestimating the fraction of “ef-
fectively neutral” amino acid substitutions.
Context-Dependent Mutation Model
Accurate estimation of selective constraints in protein-coding
regions requires a context-dependent mutational model.26 We
constructed a context-dependent mutation-rate matrix that de-
scribed the probability of de novo mutation occurrence before
any selection took place. With such a mutability model, we were
able to compare the observed number of various substitutions
with the corresponding number expected under neutrality and,
from such comparison, to draw a conclusion about the strength
of purifying selection.
We restricted our analysis to single-nucleotide substitutions,
excluding other less common types of mutations. The real mu-
tational spectrum is quite complex—CpG dinucleotides have a
mutation rate an order of magnitude higher than that of other
dinucleotides; transitions are notably more frequent than trans-
versions; and some other, more subtle, context-dependent effects
were reported to exist.27 Various mutation models of different
degrees of sophistication have been used elsewhere.28 The avail-
ability of human, chimpanzee, and (incomplete) baboon ge-
nomic sequences allowed us to calculate an empirical “directed”
mutation matrix for triplets (with probabilities for all XY1Z64# 3
to XY2Z single-nucleotide substitutions). Such a mutational
model that takes into account a nucleotide, its closest neighbors,
and the direction of substitution should capture most of the
known fine-scale mutation-rate context dependencies. We used
a second-order model of dependence on neighboring positions,
to capture all context-dependent effects on mutation rate. We
also introduced statistical correction for back substitutions in the
baboon lineage.
We made alignments of human, chimpanzee, and baboon se-
quence taken from ENCODE regions,29 using the multiple se-
quence aligner TBA.30 The frequencies of all nucleotide triplets
in the aligned sequences were counted (with any triples contain-
ing gaps ignored). Directionality of mutation (whether a substi-
tution has occurred in the human or the chimpanzee lineage)
was determined using baboon sequence.
The calculated matrix was in agreement with other recently
published context-dependent models of neutral evolution.31–33
For example, the correlation coefficient between our matrix2r
and the matrix from Siepel and Haussler31 is 96%.
Gene Sets
Population and evolutionary dynamics of genes located on sex
chromosomes differ from the rest of the genome. To avoid un-
necessary complications in our analysis, we used only autosomal
genes. To calculate the ratio of nonsynonymous to synonymous
mutations characteristic of the entire human genome, we used
14,095 reliably annotated autosomal genes from the Consensus
CDS (CCDS) Project.
Confidence of the Estimates
Analysis of human-chimpanzee divergence is based on the com-
plete proteome, and the analysis of the HGMD database incor-
porates the most comprehensive set of disease genes. However,
human SNP data are represented by much smaller gene sets.
Therefore, it is necessary to assign confidence to statistical esti-
mates obtained from these sets. Even though these data sets have
large numbers of SNPs, the mutations were found in different
genes that possess different properties. Thus, sampling errors of
the estimates are expected to be mostly determined by sampling
of genes rather than of individual mutations.
We computed SEs from SDs of estimates obtained from random
nonoverlapping subsets of the data. Although SEs are mostly used
for estimates of the mean, we tested, in a series of simulations,
that SEs computed using nonoverlapping subsets satisfactorily
approximate the error of the estimates presented in this work.
Results
Strongly Detrimental Mutations
As a first step in our analysis of the spectrum of potential
effects of amino acid mutations, we estimated the fraction
of de novo missense changes that are strongly detrimental.
We define a missense mutation as strongly detrimental
if it causes complete protein function loss, often seen in
Mendelian diseases.
Nonsense mutations that introduce premature stop co-
dons can serve as a proxy of “strong detrimentality.” Totals
of 26,305 missense and 6,764 nonsense mutations are
listed in HGMD. Although HGMD has an inherent ascer-
tainment bias, following the work of Kondrashov21 and
Yampolsky et al.,34 we believe that mutations causing the
same phenotype are equally likely to be deposited in the
database, regardless of their type—nonsense, missense, or
splice site. If all missense mutations were as likely to result
in complete loss of function and, subsequently, in strong
disease phenotype as were nonsense mutations, then the
ratio of missense to nonsense mutations in the HGMD
database would be similar to the expected theoretical ratio
for de novo mutations. In reality, it is significantly lower.
Using our mutation-rate model described above, we esti-
mated that ∼19.7 missense substitutions occur genome-
wide per nonsense substitution (14,095 human genes
from the CCDS Project were used for calculation of ge-
nomewide values). At the same time, only 3.9 missense
changes were observed per nonsense substitution among
disease-causing mutations in the HGMD database (fig. 1A).
Such a difference indicates that a large fraction of missense
mutations is not deleterious enough to be visible through
such a “strong phenotype filter” as the detection and in-
clusion in HGMD. Using the obtained numbers, we can
estimate that 20% (3.9 of 19.7) of missense mutations are
strongly detrimental.
Mutations that disrupt dinucleotides of the core splic-
ing-site consensus (GT/AG) often lead to an almost com-
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Figure 1. Spectrum of effects of de novo missense mutations.
A, Fraction of strongly detrimental mutations among de novo
amino acid substitutions. Disease-causing nonsense mutations in
HGMD were used as a standard of “strong detrimentality.” B, Frac-
tion of strongly detrimental mutations among de novo amino acid
substitutions. Disease-causing splice-site mutations in HGMD were
used as a standard of “strong detrimentality.” C, Fraction of ef-
fectively neutral mutations among de novo amino acid substitu-
tions. Synonymous substitutions fixed in the human lineage after
divergence from chimpanzee were used as a standard of “effective
neutrality.”
plete loss of gene function. These splice-site substitutions
can be used as “reference” for strongly detrimental mu-
tations in the same way that we used nonsense mutations.
We calculated that, genomewide, ∼36.5 de novo missense
mutations are expected to occur per de novo splice-site
mutation. However, in HGMD, only 7.6 missense muta-
tions are listed per mutation in the splice site (fig. 1B).
Accordingly, we can estimate that the fraction of strongly
deleterious mutations among missense mutations is
∼21%. This number is in remarkable correspondence with
the value obtained using nonsense mutations as a
reference.
Although HGMD provides a comprehensive set of dis-
ease mutations, it is very heterogeneous and includes
mutations of incomplete penetrance, gain-of-function
mutations, and possibly mutations in genes with embry-
onically lethal complete loss of function. Presence of mu-
tations in the two latter categories would bias our estimate
upward—that is, it would lead to a conservative estimate
for the purpose of this work. However, to test whether the
upward bias can be significant, we analyzed a much
smaller set of very well-characterized genes involved in
autosomal dominant or X-linked simple Mendelian dis-
eases. All mutations in this set are believed to lead to loss
of function and, for them, complete function loss is not
lethal. After individual gene lengths were taken into ac-
count, 21% of new missense mutations in the set were
estimated to be strongly detrimental.
Effectively Neutral Mutations
As the second step in our analysis of the spectrum of po-
tential effects of amino acid substitutions, we estimated a
fraction of de novo missense mutations that are effectively
neutral. We define a missense mutation as effectively neu-
tral if its probability to be fixed in the ancestral human
population after divergence from chimpanzee would have
been similar to that of synonymous substitutions. Al-
though synonymous substitutions were shown not to be
completely selectively neutral35–37 (reviewed by Chamary
et al.38), the effect on fitness of the vast majority of them
in the human population is believed to be relatively small.
We estimated (fig. 1C) that 2.23 de novo missense mu-
tations occur per synonymous mutation. However, among
substitutions fixed in the human lineage after divergence
from chimpanzee (calculated with the use of macaque ge-
nomic sequence as an outgroup) only 0.60 missense mu-
tations were present per single synonymous substitution.
The rest of the missense mutations were apparently elim-
inated by purifying selection. From these values, we can
estimate that ∼27% (0.6 of 2.23) of missense mutations
in human proteins are similar in effect to synonymous
substitutions.
This estimate is sensitive to advantageous mutations
driven to fixation by positive selection and to very slightly
deleterious mutations fixed by drift. Presence of these mu-
tations would bias our estimate of the fraction of mildly
deleterious mutations downward—that is, our estimate is
conservative for our purpose. It is also conservative with
respect to purifying selection at synonymous sites. Thus,
this estimate can be viewed as an estimate of the fraction
of new missense mutations that are not associated with
fitness loss larger than the reciprocal of effective popula-
tion size.
Mildly Deleterious Polymorphisms
We analyzed two extremes of the potential effects of
amino acid changes on fitness and estimated that, among
de novo missense mutations in human proteins, ∼20% are
strongly detrimental, whereas another 27% are effectively
neutral. Simple arithmetic provides us with the conclusion
that the majority (53%) of all de novo missense mutations
are, in fact, mildly deleterious. Mildly deleterious muta-
tions can reach low but detectable population frequencies.
We next posed a question: if the fraction of mildly de-
leterious mutations among de novo mutations is 53%,
what is the fraction of mildly deleterious alleles among
rare and common nonsynonymous SNPs in the human
population?
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Figure 2. Fraction of de novo missense mutations represented at different levels of allele frequency. The normalized fraction of de
novo amino acid substitutions detected in a given data set was calculated from the difference of observed ratio and theoreticalN /Na s
ratio expected under neutrality. Data for rare polymorphisms are shown in orange, data for common polymorphisms are in yellow,0 0N /Na s
and data for substitutions (subst.) fixed in the human lineage after divergence from chimpanzee are in green. SEs are shown by gray
error bars.
First, we considered very rare missense polymorphisms.
We analyzed only polymorphic sites at which at least
1,400 of 1,514 chromosomes have been successfully se-
quenced. More than 60% of nonsynonymous SNPs dis-
covered in our set of 37 autosomal genes sequenced in
757 individuals were detected as singletons (i.e., were
found in a heterozygote state in a single individual). Even
though singletons represent very-low-frequency SNPs, the
probability that they are de novo mutations is diminish-
ingly small. The number of nonsynonymous SNPs de-
tected at higher frequencies was significantly smaller, and,
thus, singletons represented the only group of rare mis-
sense alleles that had enough data for a statistically sig-
nificant analysis.
We estimated the relative fraction of de novo missense
mutations represented by singletons. This estimate was
based on a comparison of the observed number of non-
synonymous substitutions per synonymous mutation
( ratio) with the corresponding theoretical numberN /Na s
expected under neutral evolution ( ratio). It should0 0N /Na s
be noted that the assumption that natural selection is
absent (neutral evolution) is equivalent to the assump-
tion that natural selection has not yet acted (de novo
mutations).
As presented in figure 2 and table 1, the ratio0 0N /Na s
calculated using our neutral model of evolution for 37
genes of large resequencing data set was equal to 2.204.
Experimental ratio for singletons calculated for theN /Na s
same data set was equal to 1.49. Given these values, we
determined that only 32% ( ) of missense mu-1 1.49/2.20
tations are deleterious to the extent that there is a very
low probability that they will be found even once in the
sample of 1,500 chromosomes. SE of this estimate is 2%.
The experimental ratio for amino acid substitu-N /Na s
tions fixed in the set of 37 genes in the human lineage
after divergence from chimpanzee is equal to 0.44. This
means that ∼20% of all missense mutations in these genes
are effectively neutral—a value close to the genomewide
average.
Human genetic variation detected in the set of 37 genes
sequenced in 756 individuals provided an opportunity to
get an insight into human genetic variation of very low
allele frequency. However, it lacks a significant quantity
of data on common genetic variation. To fill this gap, we
used three publicly available data sets: (1) a data set gen-
erated by the NIEHS-EGP, in which 1500 genes involved
in DNA repair and cell-cycle pathways were sequenced in
at least 90 unrelated individuals; (2) a data set generated
by SeattleSNPs, in which 1200 genes involved in the in-
flammatory responses were sequenced in at least 46 in-
dividuals; and (3) a data set generated by JSNP, in which
polymorphic sites in 18,000 genes were discovered using
a panel of 12 individuals and were later genotyped in 750
individuals. These data sets also contained information on
rare genetic variation that we used, although a large frac-
tion of rare nonsynonymous SNPs with frequency !1%
might have been missed in the NIEHS-EGP and SeattleSNP
data sets because !200 chromosomes were sequenced and
might have been missed in JSNP because only 12 individ-
uals were used for SNP discovery.
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Table 1. Ratios of Missense to Synonymous SNPs and Substitutions
Data Set
Description
of Data Set
No. of
Genes
Theoretical
0 0N /Na s
N /Na s
0 0(N /N )/(N /N )a s a s
Singletons
SNPs with
MAF 1 25%
Substitutions
in Human
Lineage Singletonsa
SNPs with
MAF 1 25%a
Substitutions
in Human
Lineagea
CCDS Genomewide 14,095 2.232 … … .60 … … .266  .002
Obesity-related
genes
757 Individuals
sequenced
37 2.204 1.49 … .44 .68  .02 …
.20  .05
NIEHS-EGP 90–95 Individuals
sequenced
518 2.255 1.36 .56 .50 .61  .02 .26  .04
.22  .01
SeattleSNPs 46–47 Individuals
sequenced
236 2.203 1.43 .66 .66 .65  .04 .32  .05
.30  .02
JSNP 750 Individuals
genotyped
8,786 2.244 1.37b .54 .54 .61 .24
.24
a Data are mean  SE.
b SNPs with observed frequency !1% instead of singletons have been used in analysis of the JSNP data set.
Again, using our neutral model of evolution, we cal-
culated predicted ratios separately for NIEHS-EGP,0 0N /Na s
SeattleSNPs, and JSNP data sets. Then we calculated ex-
perimental ratios for three types of sequenceN /Na s
changes. The first type is rare nonsynonymous SNPs that
either (a) were observed only once among all chromo-
somes sequenced (in NIEHS-EGP and SeattleSNPs) or (b)
had an observed frequency !1% (JSNP). The second type
is very common polymorphisms, with a frequency of the
least common allele of 125%. The third type is substitu-
tions fixed in the human lineage after divergence with
chimpanzee.
We observed that the ratios for very commonN /Na s
polymorphisms were only very slightly higher than
ratios for fixed substitutions (fig. 2 and table 1). ThisN /Na s
fact indicates that the fraction of deleterious amino acid
changes among common SNPs is very low. It also supports
the notion that the fraction of positively selected amino
acid substitutions among all mutations in human proteins
was low.39
In sharp contrast with common SNPs, ratio forN /Na s
very rare alleles significantly exceeds ratios for fixedN /Na s
substitutions (that are presumably neutral). This fact in-
dicates that a very large fraction of such rare missense SNPs
are deleterious. The fraction of deleterious mutations
among observed rare substitutions can be estimated as
. Simple calculations reveal that therare rare fixed fixed(N /N )/(N /N )a s a s
majority (52%–71%) of amino acid substitutions with the
observed frequency of !1% are mildly deleterious in all
data sets (table 2). This surprising finding indicates that a
low frequency of missense mutation per se can serve as a
strong predictor of a deleterious effect of polymorphic
variants.
Characteristic Selection Coefficients of the Mildly Deleterious
Mutations Theory
We concluded that more than half of newly arising mis-
sense mutations are mildly deleterious. Such mutations
are not present among common polymorphisms but are
very common among substitutions detected only once in
100 chromosomes. On the basis of these observations,
we estimated selection coefficients associated with such
mutations.
First, we calculated the theoretical expected number of
mutations with selection coefficient s observed only once
in a set of m randomly sampled chromosomes. Then, we
divided it by the corresponding number of neutral mu-
tations to obtain the ratio :R (s)1/m
2N s 1x( )1 ee  1 m1 m1( ) ( )[mx 1 x mx 1 x ]dx∫ 2N se( )( )0 x 1 x e  1( )R sp 11/m 1 m1 m1( ) ( )[mx 1 x mx 1 x ]dx∫
0 x
(1)
In equation (1), represents an effective populationNe
size and x is the frequency of an individual allele in the
population. The number of detected mutations was ob-
tained by multiplying the theoretical number of all alleles
present in a population with frequency x by the proba-
bility of a single allele with frequency x being detected as
a singleton in a set of m chromosomes and then by in-
tegrating over allele frequency x from 0 to 1. It should be
noted that an allele is detected as a singleton in a set of
m chromosomes if either 1 or copies are present.m 1
Similarly, we calculated the theoretical ratio R (s)1MAF 0.25
for mutations that have been detected as polymorphisms
in a set of m chromosomes with minor-allele frequency
(MAF) 125%.
( )R sp1MAF 0.25
2N s 1x( )1 ee  1 j j mj( ) C x 1 x dx∫ m2N s [ ]e ! !0.25m j 0.75m( )( )0 x 1 x e  1
,
1 1 j j mj( ) C x 1 x dx∫ m[ ]
! !0.25m j 0.75m0 x
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Table 2. Fraction of Deleterious Substitutions among Rare
Missense SNPs
Set
No. of Sequenced
Individuals
Percentage of
Deleterious SNPs
among Missense
Singletonsa
Resequencing data set of
obesity-related genes 757 71  8
NIEHS-EGP 90–95 64  1
SeattleSNPs 46–47 52  6
a Data are mean  SE.
Figure 3. A, and (see eq. [1]) calculated usingR (s) R (s)11/m MAF 0.25
equations derived from diffusion theory under the assumption of
constant population size and an infinite number of sites. The
expected shift of curves due to recent population expansionR (s)1/m
is shown by red arrows. Black arrows illustrate estimation of char-
acteristic selection coefficients for a mildly deleterious class of
missense mutations (see the “Results” section and eq. [2]). B,
and calculated by direct computer simulation ofR (s) R (s)11/m MAF 0.25
molecular evolution under the assumption of an infinite number
of sites and simple population history—a stable-population-size
epoch followed by bottleneck and then fast expansion.
where is the binomial coefficient—the number of com-nCk
binations of size k from a set with n elements:
n!kC p .n ( )k!# n k !
These formulas result from an application of diffusion
theory to the dynamics of polymorphism in populations.40
Their two major underlying assumptions are constant ef-
fective population size and that each novel mutation oc-
currs at a new, previously monomorphic site (infinite-
number-of-sites model). The dominance coefficient was
assumed to be equal to 0.5, so, if s is the selection coef-
ficient associated with a heterozygote, then 2s is the se-
lection coefficient associated with a homozygote. The
exact values of the dominance coefficient are not very
important, as long as they are high enough to allow se-
lection to operate primarily on heterozygotes.
The dependence of and (for variousR (s) R (s)1MAF 0.25 1/m
values of m) on selection coefficient s is shown in figure
3A. We determined that roughly equal fractions of mis-
sense mutations can be observed as fixed substitutions and
as common polymorphisms with MAF 125% (fig. 2). This
observation implies that mildly deleterious mutations are
virtually absent among frequent SNPs and thus should
have selection coefficient values at which is veryR (s)1MAF 0.25
close to zero. On the other hand, the majority of mildly
deleterious mutations have high relative chance to be de-
tected as singletons. For each of the three resequencing
data sets (obesity-related, NIEHS-EGP, and SeattleSNPs),
we estimated the fraction of de novo mildly deleterious
missense mutations observed as singletons, relative to
neutral expectations:
singletons hum.lin.subst.( ) ( )N /N N /Na s a s
0 0 0 0( ) ( )N /N N /Na s a sR p . (2)observed hum.lin.subst.( )N /Na s1 F strongly del.
0 0( )N /Na s
Here, the numerator reflects the observed fraction of mu-
tations in the mildly deleterious class detectable as sin-
gletons, which is equal to the fraction of all mutations
detectable as singletons minus the fraction of effectively
neutral de novo mutations (“hum.lin.subst.” indicates hu-
man lineage substitutions). The denominator reflects the
total fraction of mutations arising in the mildly deleteri-
ous class. It is given by subtracting the fraction of strongly
deleterious de novo mutations (denoted by Fstrongly del.) and
neutral mutations from 1.
Using theoretical dependence of R on the selection co-
efficient (fig. 3A) for the corresponding number of se-
quenced chromosomes m, we estimated the characteristic
selection coefficients for mildly deleterious de novo mis-
sense mutation for genes in each set. All three estimates
fall into a relatively narrow range of selection coefficients:
0.002–0.02.
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Characteristic Selection Coefficients of Mildly Deleterious
Mutations: Computer Simulations
The major drawback of the straightforward theoretical ap-
proach described above is the assumption that the effec-
tive size of the human population is constant and equals
10,000. This assumption was shown to be appropriate for
common SNPs, most of which are ancient in origin. How-
ever, an effective population size that is an order of mag-
nitude larger might be more appropriate to describe the
dynamics of rare polymorphisms. A larger effective pop-
ulation size leads to more-efficient purifying selection
and, as can be seen from equation (1), to lower values
of . By underestimating , we are overestimatingR (s) N1/m e
, and, in reality, the dependence curve on sR (s) R (s)1/m 1/m
is shifted to the area of lower values of selection coeffi-
cients (fig. 3A).
To analyze the dependence of and un-R (s) R (s)11/m MAF 0.25
der a more realistic human-population-history scenario,
we simulated evolution under the Wright-Fisher model
(assuming constant mutation rate and an infinite number
of unlinked sites). Our model of human population his-
tory was comprised of the four principal epochs: (a)
100,000 generations of stable effective population size
15,000, (b) exponential reduction in 100 generations to
the size of 7,000, (c) 500 generations of stable population
size 7,000, and (d) exponential growth in 3,000 genera-
tions to the effective population size 90,000. Such a sce-
nario, where a long period of stable effective population
size is followed by bottleneck and then by rapid expan-
sion, captures key features of human population history.
Exact values for the duration of each epoch and the cor-
responding effective population sizes were chosen in gen-
eral agreement with recent literature41–43 and then were
slightly optimized to better describe allele frequency dis-
tributions for noncoding SNPs detected by the NEIHS-EGP.
Usage of and dependencies obtainedR (s) R (s)11/m MAF 0.25
using direct simulation resulted in the estimate that
the ∼0.001–0.003 range of selection coefficients cor-
responds to a mildly deleterious class of de novo missense
mutations.
Cumulative Equilibrium Frequency of Mildly Deleterious
Polymorphisms in the Human Genome
We determined that mildly deleterious missense mu-
tations that are not present among common polymor-
phisms are nevertheless numerous among polymorphisms
with a detected population frequency !1% and are asso-
ciated with selection coefficients in the range of 0.001–
0.003. Using this result, we estimated the equilibrium fre-
quency of such mildly deleterious alleles in the human
population. Under the assumption of strong selection and
large population size ( ), the cumulative equilib-N # sk 1e
rium frequency of all mildly deleterious gene alleles in the
population is
u
frequency p , (3)cumulative s
where u is mutation rate per gene per generation and s is
selection coefficient associated with heterozygotes. We
used as the mutation per nucleotide per gener-82# 10
ation rate, estimated by Kondrashov.21 Importantly, this
estimate for cumulative frequency of deleterious alleles
does not depend on population demographic history.
The mutation rate for mildly deleterious missense mu-
tations per gene can be estimated as follows:
up (mutation rate per nucleotide)
#(average gene length)
#(fraction of missenses among
all de novo mutations) ,
or, by substitution of numbers,
8up (2# 10 )# (1,500)# (2.23/3.23)# (0.53)
5p 1.1# 10
Using equation (3), we calculate that, for an average gene,
the combined frequency of alleles carrying mildly dele-
terious missense mutation is ∼1%.
Taking into account that protein-coding sequences
compose ∼1.5% of the human genome, we estimated that
∼600 missense mutations with selection coefficient in the
range 0.001–0.003 are present in the genome of an average
individual. It should be noted that the number of muta-
tions with significantly weaker effect on fitness (with as-
sociated selection coefficients !104) is likely to be signif-
icantly higher.
Discussion
It has been noted that, in some Mendelian diseases, less
severe forms of the disease exist that are associated with
milder mutations that do not completely abrogate protein
activity.1 It was suggested that such mildly deleterious mis-
sense mutations may serve as a genetic basis of complex
diseases. The plausibility of this hypothesis depends on
how frequent such mildly deleterious substitutions are
among de novo mutations and how strong the purifying
selection that acts on them is. The presence of deleterious
missense polymorphisms in the human genome has been
reported in many previous studies.44–55 In the present
work, we performed a quantitative analysis, calculating
the fraction of mildly deleterious mutations among de
novo amino acid changes and very rare and very common
nonsynonymous SNPs. Until recently, a lack of large re-
sequencing data sets that cover dozens of genes and hun-
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dreds of chromosomes precluded such analysis, although
several earlier studies analyzed distribution of selection
coefficients for new missense mutations in humans and
flies by use of the dependence of substitution rate on
effective population size,56–58 a comparison of polymor-
phism and divergence,34,55,58 and a frequency spectrum in
smaller samples.54,58,59
We calculated the fraction of mildly deleterious mis-
sense mutations among all de novo substitutions as the
remaining difference after subtraction of strongly detri-
mental mutations and effectively neutral mutations. We
determined that, among all de novo amino acid substi-
tutions, strongly detrimental mutations comprise ∼20%.
The genomewide value that we obtained is similar to the
fraction of amino acid replacements that destroy the pro-
tein function (25%), obtained by Yampolsky et al.34 Our
estimate is also in general agreement with the results of
Eyre-Walker et al.,54 who, by fitting a distribution of se-
lection coefficients modeled as a gamma function to the
data on human genetic variation, estimated that ∼15% of
missense substitutions are strongly deleterious, with se-
lection coefficients 10.1. Earlier, Fay et al.55 proposed that
54% of new missense mutations in humans are strongly
deleterious. This estimate referred to the fraction of non-
synonymous SNPs not observed in the sample of 100 chro-
mosomes, so this estimate is not directly comparable to
the estimate presented here. Our value for the fraction of
effectively neutral amino acid changes (27%) is only
slightly higher than a previous estimate51 of 24% and the
corresponding KAKS estimate
39 for human-chimpanzee
comparison (23%). The difference is most likely because
of the application of a context-based mutation model. A
smaller previous estimate34 of 12% possibly resulted from
the use of the too-distant mouse sequence as an outgroup.
On the basis of a very strong difference in the N /Na s
ratios for very rare and very common missense SNPs, we
estimated that the majority of rare missense polymor-
phisms detected in the human population are associated
with a surprisingly narrow range of selection coefficients:
0.001–0.003. Because of such relatively mild purifying se-
lection acting on them, they can reach a high cumulative
frequency in the human population while still maintain-
ing a highly heterogeneous spectrum of individual alleles.
An increase in the ratio has been noted else-N /Na s
where44; however, the extent of such a difference was not
always evident, because of the low number of chromo-
somes sequenced and crude binning by frequency. A
strong “threshold-like” increase in the ratio for SNPsN /Na s
with frequency !6% was noted by Wong et al.60 This
work,60 however, has not analytically treated the possi-
bility that the observed effect is the consequence of the
shape of selection coefficients distribution for de novo
mutations.
We estimated that, for an average 500-aa protein, the
cumulative equilibrium frequency of alleles carrying del-
eterious missense SNPs is roughly equal to 1% in the hu-
man population. If we consider unusually long proteins
or entire pathways as mutational targets, their mutation
rate and, thus, the equilibrium frequency of mildly del-
eterious alleles will be significantly higher than 1%. Some
traits, such as susceptibility to complex diseases, can be
influenced by dozens, or perhaps even hundreds, of genes.
The mutational target for such traits will be exceptionally
large. A large mutational target size leads to a large mu-
tation rate per generation and, as a consequence, to a large
level of deleterious polymorphism, since, at equilibrium,
it is directly proportional to the mutation rate. Even for
a simple metabolic pathway that involves several multi-
subunit enzymes, the percentage of individuals harboring
at least one damaging mutation in the pathway can easily
exceed 10%. This example shows that a combined fre-
quency of rare mildly deleterious polymorphisms is high
enough to serve as the basis for heritable susceptibility
even to most of the common complex diseases, such as
hypertension or coronary heart disease. This suggests the
possibility that mutation-selection balance can be a fea-
sible evolutionary explanation at least for some common
diseases.
Candidate-Gene Association Studies
These findings have implications not only for our under-
standing of the role of rare nonsynonymous SNPs in sus-
ceptibility to complex diseases but also for methods of
detecting genes that harbor such detrimental genetic var-
iation. Currently, there are two major approaches for iden-
tification of genes involved in complex diseases: linkage
studies61 and association studies of population samples.61,62
Whereas the former approach is the most effective for
identification of Mendelian-like rare genetic variants with
high penetrance, the latter approach is better suited for
identification of common variants with relatively low pen-
etrance. None of these approaches, however, is able to
detect susceptibility loci that harbor numerous, but in-
dividually rare, mildly deleterious polymorphisms. How-
ever, our analysis of mildly deleterious mutations indicates
that this situation is very plausible and might be true for
many genes and common diseases.
In the light of our results, a recently proposed alterna-
tive approach looks more promising. This approach aims
at the detection of enrichment in rare, potentially dele-
terious missense SNPs in a patient group compared with
a control group.63,64 By considering the cumulative fre-
quency of deleterious mutations rather than their indi-
vidual frequencies, this method is suitable for investiga-
tion of common diseases that have a very heterogeneous
spectrum of predisposing alleles. Such a missense-accu-
mulation approach to candidate-gene association studies
has been successfully used recently in studies of the MC4R
gene,65 tyrosine phosphatome in colorectal cancers,66 and
genes involved in lipid-metabolism disorders.67
However, two major potential disadvantages of this
method have been identified.63 First is the high cost of
complete genomic sequencing of candidate genes in a
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large number of individuals. Second is the analytical chal-
lenge of selecting potentially deleterious SNPs from a large
quantity of neutral genetic variation.63 The first objection
to the method will almost certainly be eliminated in the
near future by the continuing dramatic reduction in se-
quencing costs68 and the development of novel sequenc-
ing strategies.69 The second objection is more fundamen-
tal, since the inability to distinguish between deleterious
and neutral amino acid changes would lead to a very low
signal:noise ratio. To study enrichment in deleterious mu-
tations, one should be able to detect them among neutral
genetic variation. The number of deleterious alleles in dis-
ease phenotypes was previously believed to be low relative
to the large number of neutral missense SNPs present in
both disease and control groups. Our analysis, however,
reveals that the majority of missense substitutions with
detected frequency !1% are, in fact, deleterious. Thus, if
only substitutions with detected frequency !1% are
counted, the enrichment in the mutation number in a
disease group should be highly pronounced.
Conclusions
A large fraction of mildly deleterious mutations among
missense mutations suggests that mutation-selection bal-
ance is a plausible explanation for the existence of com-
mon disease with complex inheritance, at least in some
cases. Furthermore, it is feasible that some common dis-
eases may be caused by a multitude of rare allelic variants.
The observation that the majority of human rare nonsy-
nonymous variants are deleterious, and thus are of sig-
nificance to function and phenotype, suggests a strategy
for candidate-gene association studies. Disease popula-
tions are expected to have a higher rate of rare amino acid
variants in genes involved in disease than are healthy con-
trol populations. This difference can be easily detected in
a deep resequencing study. Obviously, this strategy would
be highly inefficient if the majority of coding variants at
low frequency were neutral. Several recent reports dem-
onstrated an excess of rare missense variants in individuals
with phenotypes associated with disease risk. Our analysis
provides an explanation for the success of these studies.
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